Skip to main content

Table 2 Predicted mammographic measures in women 60 and 70 years old by menopausal hormone therapy use

From: Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study

  PMD (%) DA (cm2) NDA (cm2)
Predicted (95% CI) Predicted (95% CI) Predicted (95% CI)
For a woman aged 60 years
 Never 24 (22 to 26) 24 (22 to 26) 78 (72 to 83)
 Past use 29 (27 to 31) 29 (26 to 31) 71 (66 to 76)
 Current use 33 (31 to 35) 33 (31 to 35) 67 (63 to 70)
For a woman aged 70 years
 Never 20 (18 to 23) 24 (21 to 27) 94 (87 to 101)
 Past use 25 (22 to 27) 29 (26 to 32) 87 (80 to 93)
 Current use 29 (26 to 32) 33 (30 to 37) 82 (75 to 89)
  1. PMD percent mammographic density, DA dense area, NDA non-dense area, MHT menopausal hormone therapy